Methods for Identifying Out-of-Trend Data in Analysis of Stability Measurements—Part II: By-Time-Point and Multivariate Control Chart
In Part I of this article series, the authors discussed the regression control chart method for identifying out-of-trend data in pharmaceutical stability studies. In Part II, the by-time-point method and the multivariate control chart method are investigated, and improved approaches are suggested. The method is illustrated using real data sets.
kentoh/shutterstock.com
Abstract
This article is a continuation of Part I, in which the authors discussed the identification of out-of-trend (OOT) data in the stability studies of single batches using a regression control chart method (1).
If several batches are considered, there are two different time scales. The first one is the life within batches, which has been covered in Part I (1). The regression control chart uses this within-batch context. The second time scale is the order of batches. Two approaches are followed in this Part II article. The by-time-point method uses the between-batches context only, while the multivariate approach uses both between-batches and within-batches contexts.
Click here to view a PDF of this article.Peer-Review Article
Submitted: April 5, 2017
Accepted: June 27, 2017
About the Authors
Máté Mihalovits is a PhD student, mihalovits@mail.bme.hu; and Sándor Kemény* is an emeritus professor, Tel.: +36 309936307, kemeny@mail.bme.hu, both at Budapest University of Technology and Economics, Faculty of Chemical Technology and Biotechnology, Department of Chemical and Environmental Process Engineering Hungary, 1111. Budapest, Műegyetem rakpart 3.
* To whom all correspondence should be addressed.
Article Details
Pharmaceutical Technology
Vol. 41, No. 12
December 2017
Pages: 38–43, 45
Citation:
When referring to this article, please cite it as M. Mihalovits and S. Kemény, "Methods for Identifying Out-of-Trend Data in Analysis of Stability Measurements–Part II: By-Time-Point and Multivariate Control Chart," Pharmaceutical Technology 41 (12) 2017.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
